How To Understand The Resurgence of Eugenics
By Sydney Perkowitz,
JStor Daily [cites CGS]
| 04. 05. 2017
In 1883, the English statistician and social scientist Francis Galton coined the word “eugenics” (“well-born,” from Greek). The term referred to his idea of selectively breeding people to enhance “desirable” and eliminate “undesirable” properties. Seen as following Darwin’s theory of evolution, in the 1920s and ’30s eugenics gained important backing in England and the United States. Scientists and physicians spoke and wrote in its support. It influenced U.S. immigration policy, and states like Virginia used it to justify the forcible sterilization of the intellectually disabled.
Today’s growing anti-immigrant and white nationalist movements are raising concerns about a return of this long discredited dogma. For instance, U.S. Congressman Steve King (R-Iowa) recently tweeted about a far-right movement in Europe, calling Western culture “superior” and saying, “We can’t restore our civilization with somebody else’s babies.” King hoped for “an America that’s just so homogenous that we look a lot the same.”
At the same time, we are seeing an advance in methods of manipulating human DNA that, though they present many benefits, could also be used to advance eugenic goals. This...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...